Kevin Conroy
Chairman and CEO
Joined Exact Sciences in 2009
Kevin Conroy became CEO of Exact Sciences in 2009 and chairman in 2014, transforming the organization into one of the world’s premier cancer diagnostics companies, with more than 6,500 employees. Under his leadership, Exact Sciences is working to change the future of cancer care through innovative tests that help prevent cancer, detect it earlier, and guide successful treatment.
Conroy led Exact Sciences through the development and commercialization of its noninvasive colorectal cancer screening test, Cologuard®, which became the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the United States. The company also provides the Oncotype DX® test, which has spared more than one million breast cancer patients from chemotherapy while helping to predict the risk of their cancer returning.
Conroy has overseen the acquisition of more than 10 companies, including Genomic Health, Thrive, PreventionGenetics, Ashion, and Biomatrica, growing Exact Sciences and positioning it for future success. Building on its strong foundation, the company has a robust pipeline that includes tests for multi-cancer early detection and molecular residual disease.
Before joining Exact Sciences, Conroy served as CEO and president of Third Wave Technologies, held leadership positions at GE Healthcare, and practiced intellectual property law in private practice.
Conroy serves on the board of the American Clinical Laboratory Association and Align Technology. He is active in the Wisconsin community, serving as a director of the Greater Madison Chamber of Commerce.
He has spoken at industry-leading events, including the STAT Summit, HLTH, and the Personalized Medicine Conference.
A native of Flint, Michigan, he holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his law degree from the University of Michigan Law School.
Working at Exact Sciences allows me to be part of a team that is solving challenging problems. We have ambitious goals to help patients and reduce global cancer mortality by 30%. Our portfolio of tests is unlike any in healthcare, and we're surrounding it with best-in-class wraparound services that support patients and providers. I'm grateful to wake up every morning and have the chance to work with exceptional people.
